(EMAILWIRE.COM, April 16, 2021 ) The study involved four major activities in estimating the current Synthetic Stem Cells Market. Exhaustive secondary research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. The top-down approach was employed to estimate the complete market size.

Secondary Research;

In the secondary research process, various secondary sources such as Hoovers, Bloomberg Business Week, Forbes, and Dun & Bradstreet were referred to, to identify and collect information useful for this technical, market-oriented, and commercial study of the synthetic stem cells industry. These secondary sources included annual reports, press releases & investor presentations of companies; white papers; certified publications; articles by recognized authors; gold standard & silver standard websites; food safety organizations; regulatory bodies; trade directories; and databases.

According to the new market research report “Synthetic Stem Cells Market by Application (Cardiovascular Disease, Neurological Disorders, Other Applications (Cancer, Diabetes, Gastrointestinal, Musculoskeletal Disorders)), Region (North America (US, Canada), Europe, APAC, RoW) – Global Forecast” published by MarketsandMarkets™, the ethical concerns on the use of embryonic stem cells and the risk of tumor formation and immune response to natural stem cells are the key factors driving the growth of this market.

Expected Revenue Surge: The Synthetic Stem Cells Market is expected to grow from USD 14 million in 2023 to USD 37 million by 2028, at a CAGR of 22.5% during the forecast period

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=4959435

Geographical Scenario in Depth:

North America is estimated to account for the largest share of the Synthetic Stem Cells Market in 2023. This is majorly attributed to the rising research on stem cells in the region, coupled with public-private funding. The region is a global leader in the research on regenerative therapies such as stem cells and is backed by funding on advanced research infrastructure to commercialize novel regenerative therapies. Moreover, North America is the pioneer of synthetic stem cell technology and will be the early adopter of this technology in the coming years.

Leading Key-Players:

The technology is developed and patented by North Carolina State University (NCSU) (US) and Zhengzhou University (China).

In line with the rising importance of stem cell, researcher Ke Cheng, an associate professor at North Carolina State University, and his research partner Dr. Thomas Caranasos of the University of North Carolina School of Medicine created a protocol to harvest the healing factors secreted by the heart stem cells and encapsulate them synthetically. This offers a breakthrough in cardiac treatment using these artificial stem cells. The study was conducted in animal models and is expected to require five more years to be conducted on humans. This ‘platform technology’ is expected to be a breakthrough in the field of stem cell therapy in the coming years.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=4959435